about
Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancerStrategies for revealing lower abundance proteins in two-dimensional protein maps.Proteomic analysis and characterisation of human cervico-vaginal fluid proteins.Phase II biomarker trial of a multimarker diagnostic for ovarian cancerThe effect of pre-existing maternal obesity on the placental proteome: two-dimensional difference gel electrophoresis coupled with mass spectrometry.Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.5 Beta-dihydroprogesterone and steroid 5 beta-reductase decrease in association with human parturition at term.Prediction of spontaneous preterm labour in at-risk pregnant women.Evaluation of midkine and anterior gradient 2 in a multimarker panel for the detection of ovarian cancer.Phospholipase A2 isozymes in pregnancy and parturition.Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis.Differential Regulation of Eicosanoid and Endocannabinoid Production by Inflammatory Mediators in Human Choriodecidua.Performance of a multianalyte test as an aid for the diagnosis of ovarian cancer in symptomatic women.Epigenetic regulation of cytokine production in human amnion and villous placenta.The role and regulation of the nuclear factor kappa B signalling pathway in human labour.Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma.Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma.Why do membranes rupture at term? Evidence of increased cellular apoptosis in the supracervical fetal membranes.Multicellular spheroids in ovarian cancer metastases: Biology and pathology.The role of gangliosides in brain development and the potential benefits of perinatal supplementation.Proteomic profiling of proteins associated with urokinase plasminogen activator receptor in a colon cancer cell line using an antisense approach.Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.TLR ligands of ryegrass pollen microbial contaminants enhance Th1 and Th2 responses and decrease induction of Foxp3(hi) regulatory T cells.Human labour is associated with decreased cytoplasmic FoxO4.Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition.Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells.Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.Lipopolysaccharide and TNF-alpha activate the nuclear factor kappa B pathway in the human placental JEG-3 cells.Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer.The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor MicroenvironmentSecretory phospholipases and membrane polishing.Identification of differentially regulated proteins in a patient with Leber's Congenital Amaurosis--a proteomic study.Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid.Cell-free 59 kDa immunoreactive integrin-linked kinase: a novel marker for ovarian carcinoma.Regulation of phospholipase isozymes by nuclear factor-kappaB in human gestational tissues in vitro.Repression of oxidant-induced nuclear factor-kappaB activity mediates placental cytokine responses in gestational diabetes.Effect of bacterial endotoxin on the in vitro release of Type II phospholipase-A2 and prostaglandin E2 from human placenta.Effect of nuclear factor-kappa B inhibitors and peroxisome proliferator-activated receptor-gamma ligands on PTHrP release from human fetal membranes.Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kRelease and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies.
P50
Q30763413-19AFB9E4-C063-4B40-B4DD-B29EECDC49B9Q31141586-5F7C7FB9-068B-4EF7-9AE8-00E982C7F2DDQ33270731-99644350-E29E-43EC-A570-61ADF3E257FBQ33868802-6F4C18AE-2259-410F-8316-C892309ECFEEQ34149507-94774791-36E0-400E-AA24-9188C5A64453Q34244781-6B3568EB-0521-44E1-BF2A-A7A6F461E228Q34445774-EB734094-D714-498F-A924-03A470285F4CQ34822745-313DA341-E830-479E-9249-386310D6FC3CQ35180145-BF7570AA-95D1-4D1B-96DC-0266C86348FAQ35610802-7C767216-37F4-426E-BC27-65CBF19A830CQ35906208-2E4F9050-79CF-4CD2-9DD8-71342165AF37Q35913259-306B1C84-80EE-4D5A-9234-0C0048ED6B19Q35922723-02E25371-DC62-4ED8-86F3-0370B8330792Q35991082-6F79C7F0-9271-4AD8-9AE3-A4F2978D4EB0Q36537210-0448A854-2B1D-4111-9E9B-EB1D9012557BQ36615765-B8BA4359-2FA1-4996-B768-A5845864ED5EQ36616741-FFB9C89A-C71C-45E2-8CDD-9AA9D24832B7Q36805206-E636FDFD-887E-4695-8A33-EB291427A189Q37366009-203E855E-9830-43A3-A40C-04C03146A574Q38157239-124D43FF-0874-46B8-BB33-972E8591A1AFQ38356887-51C0A661-F2F3-40F3-ACC6-E79DF2EE5F46Q38601915-E50B1E16-770C-4679-A465-999A0C5B1257Q39226435-02CFEF8B-3D25-486B-B7E9-41B4E73E144AQ39438081-1682A28E-B4F2-4F75-996E-59F65BCFF5C6Q40172148-3D397C32-AB4E-4152-AB84-3D959B417FD6Q40279036-8636187C-F111-4953-88AC-66338BE928DFQ40352144-ECD0267B-227A-4EFD-9C32-8AB0D2C5A58DQ40381493-AD44B3BC-BC6A-4289-B90B-C4B1B9B71B60Q40752107-1FEC6AAE-ED06-412C-83C5-3084E7AAF535Q41341695-A9148928-1194-4B76-AA9B-0E6C9993C4A5Q41712030-3E0C4834-F3CD-4152-8748-AC7CF678265DQ41824151-4B6916FC-63F3-4161-B5AD-2350A959E440Q42450835-31FD091C-22BE-4435-AD9A-2FAB3A4E54A3Q42459911-43E599C4-0612-4174-8FB1-32B515BC2347Q42461169-7914B1A5-EF14-4C8E-A95A-672413D94C22Q42464297-C8356DD9-946C-4007-A0B8-CEC9E3924080Q42467174-08C158F0-89D9-4110-80B0-1DBC30161825Q42468329-52741037-94DC-493C-B427-F2D247CD0396Q42478553-93712F31-CC84-4113-B12E-C53D13537798Q42483385-F5B881AA-2CE0-42DC-8809-1CF9780A7CF4
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gregory E Rice
@nl
Gregory E Rice
@sl
Gregory E. Rice
@en
Gregory E. Rice
@es
type
label
Gregory E Rice
@nl
Gregory E Rice
@sl
Gregory E. Rice
@en
Gregory E. Rice
@es
prefLabel
Gregory E Rice
@nl
Gregory E Rice
@sl
Gregory E. Rice
@en
Gregory E. Rice
@es
P1053
F-2412-2010
P106
P1153
36004505600
57132198700
P21
P31
P3829
P496
0000-0001-7177-0246